Drug Profile
LY 03001
Alternative Names: LY-03001Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Luye Pharma Group
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Neurological-disorders in China